Corticosteroids and prostate cancer: friend or foe?

Eur Urol. 2015 May;67(5):874-5. doi: 10.1016/j.eururo.2014.08.008. Epub 2014 Aug 20.

Authors

Daniel M Geynisman¹, Russell Z Szmulewitz², Elizabeth R Plimack³

Affiliations

¹ Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.
² Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
³ Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address: Elizabeth.Plimack@fccc.edu.

PMID: 25151018
DOI: 10.1016/j.eururo.2014.08.008

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenal Cortex Hormones / blood*
Androstenes / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Humans
Male
Neoplasm Metastasis / drug therapy*
Prednisone / therapeutic use*
Prostatic Neoplasms, Castration-Resistant / drug therapy*

Substances

Adrenal Cortex Hormones
Androstenes
Prednisone